Compare AZN & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | SAN |
|---|---|---|
| Founded | 1992 | 1857 |
| Country | United Kingdom | Spain |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7B | 207.6B |
| IPO Year | 1995 | 1994 |
| Metric | AZN | SAN |
|---|---|---|
| Price | $156.63 | $13.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | ★ $212.17 | $14.79 |
| AVG Volume (30 Days) | 2.7M | ★ 6.3M |
| Earning Date | 10-30-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.06% | 1.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.55 | $2.29 |
| Revenue Next Year | $6.07 | $8.92 |
| P/E Ratio | $31.91 | ★ $11.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $80.48 | $9.62 |
| 52 Week High | $212.71 | $15.00 |
| Indicator | AZN | SAN |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | 43.81 |
| Support Level | $154.89 | $11.75 |
| Resistance Level | $169.77 | $14.39 |
| Average True Range (ATR) | 2.84 | 0.24 |
| MACD | -0.73 | -0.11 |
| Stochastic Oscillator | 12.72 | 43.75 |
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Santander runs five global businesses: retail and commercial banking, corporate and investment banking, wealth management and insurance, payments, and a digital platform Openbank. Spain is the largest single profit contributor, followed by Brazil, the United States, Mexico and the United Kingdom.